Mélanie Bousquenaud, Fatiha Maskali, Sylvain Poussier, Pierre-Yves Marie, Henri Boutley, Gilles Karcher, Daniel R Wagner, Yvan Devaux
Index: Int. J. Cardiovasc. Imaging 28(6) , 1407-15, (2012)
Full Text: HTML
The rat myocardial infarction (MI) model is widely used to study left ventricular (LV) remodeling. In this study, acipimox-enhanced (18)F-Fluorodeoxyglucose (FDG) gated-positron emission tomography (PET) was assessed for characterizing and predicting early remodeling in the rat infarct model. Nineteen Wistar rats had surgical occlusion of the left anterior descending coronary artery and 7 were sham-operated. PET was scheduled 48 h and 2 weeks later for quantifying MI area and LV function. Segments with <50% of FDG uptake had histological evidence of MI (74 ± 9% decrease in parietal thickness, fibrosis development). At 48 h, MI area was large (>35% of LV) in 6 rats, moderate (15-35% of LV) in 8 rats, limited (<15% of LV) in 5 rats and absent in the 7 sham rats. LV remodeling, assessed through the 2 weeks increase in end-diastolic volume, increased between rats with limited, moderate and large MI (+72 ± 25, +109 ± 56, +190 ± 69 μl, respectively, P = 0.007). This 3-groups classification allowed predicting 44% of the 2 weeks increase in end-diastolic volume, and additional 34% were predicted by heart rate at 48 h. The acipimox-enhanced FDG gated-PET technique provides efficient characterization and prediction of early remodeling in the rat infarct model.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Acipimox
CAS:51037-30-0 |
C6H6N2O3 |
Kinetics and utilization of lipid sources during acute exerc...
2014-07-15 [Am. J. Physiol. Endocrinol. Metab. 307(2) , E199-208, (2014)] |
The lowering of hepatic fatty acid uptake improves liver fun...
2008-08-01 [Am. J. Physiol. Endocrinol. Metab. 295(2) , E413-9, (2008)] |
ECG-triggered 18F-fluorodeoxyglucose positron emission tomog...
2010-08-01 [Eur. J. Nucl. Med. Mol. Imaging 37(9) , 1745-50, (2010)] |
Effects of acute and one-week fatty acid lowering on cardiac...
2012-09-01 [J. Clin. Endocrinol. Metab. 97(9) , 3277-84, (2012)] |
The diagnosis of GH deficiency in obese patients: a reapprai...
2010-08-01 [Eur. J. Endocrinol. 163(2) , 201-6, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved